Key facts
- This page summarizes Vafa Jamali's Form 4 filing for ZimVie Inc. (ZIMV).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 07 Mar 2022, 18:11.
Vafa Jamali - 01 Mar 2022 Form 4 Insider Report for ZimVie Inc. (ZIMV)
- Reporting relationship
- President and Chief Executive Officer, Director
- Issuer ticker
- ZIMV
- Reported as of
- 01 Mar 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 Mar 2022, 18:11:33 UTC
- Prior SEC filing
- 07 Feb 2022
- Next SEC filing
- 10 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Heather Kidwell, Attorney-in-Fact for Vafa Jamali
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Vafa Jamali filed Form 4 for ZimVie Inc. (ZIMV) on 07 Mar 2022.
Change
- Previous filing in this sequence was filed on 07 Feb 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ZIMV
transaction
Common Stock
Award
- Transaction value
- Shares
- +39,186
- Change %
- +261240%
- Price
- Shares after
- 39,201
- Date
- 01 Mar 2022
- Ownership
- Direct
- Footnotes
- F1, F2, F3
ZIMV
transaction
Common Stock
Award
- Transaction value
- Shares
- +54,789
- Change %
- +140%
- Price
- Shares after
- 93,990
- Date
- 01 Mar 2022
- Ownership
- Direct
- Footnotes
- F1, F3, F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ZIMV
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +172,206
- Change %
- Price
- Shares after
- 172,206
- Date
- 01 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 172,206
- Exercise price
- $32.26
- Footnotes
- F1, F5, F6
ZIMV
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +200,276
- Change %
- Price
- Shares after
- 200,276
- Date
- 01 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 200,276
- Exercise price
- $32.42
- Footnotes
- F1, F5, F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
On March 1, 2022, Zimmer Biomet Holdings, Inc. ("Zimmer Biomet") completed a pro rata spinoff distribution (the "Distribution") of shares of ZimVie Inc. ("ZimVie") common stock, par value $ 0.01 per share ("ZimVie Common Stock") to the holders of record of Zimmer Biomet common stock, par value $ 0.01 per share ("Zimmer Biomet Common Stock") on February 15, 2022. In connection with the Distribution, pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2022, between Zimmer Biomet and ZimVie (the "EMA"), all outstanding equity awards with respect to Zimmer Biomet Common Stock held by the Reporting Person were equitably adjusted and converted into equity awards with respect to ZimVie Common Stock, with such equitable adjustments determined based on (i) the volume weighted average trading price of Zimmer Biomet Common Stock on February 28, 2022 and (ii) the volume weighted average trading price of ZimVie common stock on March 1 through March 3, 2022.
Footnote F2
Represents the grant of restricted stock units with respect to ZimVie Common Stock ("ZimVie RSUs") upon the conversion of performance-based restricted stock units with respect to Zimmer Biomet Common Stock held by the Reporting Person as of March 1, 2022 in accordance with the terms of the EMA. The ZimVie RSUs vest on February 25, 2024.
Footnote F3
Reflects 15 shares of ZimVie Common Stock received in the Distribution in respect of shares of Zimmer Biomet Common Stock held by the Reporting Person as of the record date for the Distribution.
Footnote F4
Represents the grant of ZimVie RSUs upon the conversion of restricted stock units with respect to Zimmer Biomet Common Stock held by the Reporting Person as of March 1, 2022 in accordance with the terms of the EMA. The ZimVie RSUs vest ratably in four annual installments on the first four anniversaries of the grant date, March 1, 2021. 13,700 shares of ZimVie Common Stock included in this award vested on March 1, 2022.
Footnote F5
Represents the grant of stock options to purchase ZimVie Common Stock upon the conversion of stock options to purchase Zimmer Biomet Common Stock in accordance with the terms of the EMA.
Footnote F6
This option vests ratably in four annual installments on the first four anniversaries of the grant date, February 25, 2021.
Footnote F7
This option vests ratably in four annual installments on the first four anniversaries of the grant date, March 1, 2021.
SEC remarks
President and Chief Executive Officer